Valérie Cayron-Elizondo, Head of Pharmacovigilance, DNDi

Dr Valérie Cayron-Elizondo is contributing to DNDi’s activities, from February 2014 as Consultant, and Valérie officially joined DNDi in April 2016.

She is leading DNDi‘s Pharmacovigilance team, supporting all DNDi programmes and associated clinical-safety activities.

Valérie, who most recently served as European Union Qualified Person for Pharmacovigilance (EU-QPPV) at Novartis Consumer Health (GSK CH Joint Venture), had formerly set-up and led PregLem’s Pharmacovigilance and Medical Information department (as Vice-President and acting as EU-QPPV). She has 20 years of experience in global and clinical development (from translational medicine to phase I/II/III/IV of development and post-marketing studies; with Synthelabo, Merck Serono and Preglem) followed by significant pharmacovigilance experience (development and marketed products) from 2008.

Dr Valérie Cayron-Elizondo graduated as Pharmacy Doctor from University of Châtenay-Malabry, Paris in 1989.